GO:1903347 negative regulation of bicellular tight junction assembly: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903347 describes any process that stops, prevents, or reduces the frequency, rate, or extent of bicellular tight junction assembly.
• Tight junctions are apical junctional complexes that regulate paracellular permeability and maintain epithelial polarity.
• Negative regulation of tight junction assembly is critical for tissue remodeling, barrier modulation, and disease pathogenesis.
• Key molecular players include polarity complexes (Par-3, aPKC), Rho GTPases (Rac1, RhoA), and junctional proteins (claudins, ZO proteins) [2,4,7,8].
• Dysregulation of this process is implicated in cancer progression, inflammatory bowel disease, and microbial pathogenesis [1,5].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of regulatory mechanisms [2,6,8].
Description
Tight junctions are specialized membrane domains that seal the paracellular space between adjacent epithelial or endothelial cells, controlling the passage of ions, solutes, and water. The assembly of these junctions is a highly dynamic process that must be tightly regulated to accommodate physiological needs such as tissue remodeling, wound healing, and barrier adaptation. GO:1903347, negative regulation of bicellular tight junction assembly, encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of tight junction assembly. This regulatory term is essential for understanding how cells modulate barrier function in response to environmental cues, microbial signals, and developmental programs [1,5]. Research into negative regulation of tight junction assembly has revealed intricate crosstalk between polarity complexes, small GTPases, and junctional proteins [2,4,7,8]. For example, the Par-3/aPKC polarity complex can influence tight junction formation through Rac1 activation, while IQGAP1 differentially regulates claudin recruitment [2,8]. Dominant-negative E-cadherin expression has been shown to increase the extent of tight junction assembly, indicating that cadherin function can negatively regulate this process. These findings highlight the importance of understanding the molecular brakes that prevent premature or excessive junction assembly. Dysregulation of tight junction assembly is linked to numerous human diseases, including cancer, inflammatory bowel disease, and microbial infections [1,5]. Therefore, studying GO:1903347 provides insights into basic cell biology and offers potential therapeutic targets for barrier-related disorders [1,5]. This article synthesizes current knowledge based on authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview for researchers.
negative regulation of bicellular tight junction assembly At A Glance
| GO ID | GO:1903347 |
|---|---|
| GO term | negative regulation of bicellular tight junction assembly |
| Ontology | biological_process |
| Synonym | down regulation of tight junction assembly; down-regulation of tight junction assembly; downregulation of tight junction assembly; down regulation of tight junction formation; down-regulation of tight junction formation; downregulation of tight junction formation; inhibition of tight junction assembly; inhibition of tight junction formation; negative regulation of tight junction formation |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of tight junction assembly |
| Related cellular component | Bicellular tight junction |
| Related biological process | Tight junction assembly; cell-cell junction organization |
| Regulatory direction | Negative |
What Is GO:1903347?
GO:1903347, negative regulation of bicellular tight junction assembly, is a biological process defined by QuickGO as any process that stops, prevents, or reduces the frequency, rate, or extent of tight junction assembly. In other words, it encompasses molecular events that inhibit or downregulate the formation of tight junctions between two cells. This term is a child of negative regulation of cell-cell junction assembly and is distinct from positive regulation or the assembly process itself. Synonyms include downregulation of tight junction assembly, inhibition of tight junction formation, and negative regulation of tight junction formation.
Why Is negative regulation of bicellular tight junction assembly Important in Cell Biology?
Understanding negative regulation of bicellular tight junction assembly is crucial because tight junctions are central to epithelial barrier function, and their dynamic regulation impacts tissue homeostasis, immune responses, and disease progression. Many pathogens and inflammatory cytokines disrupt tight junctions by activating negative regulatory pathways, leading to increased permeability and disease symptoms. Moreover, cancer cells often exploit mechanisms that negatively regulate tight junction assembly to promote invasion and metastasis. Thus, deciphering these regulatory mechanisms can reveal therapeutic targets for barrier-related diseases.
• Maintains epithelial barrier integrity by preventing inappropriate or premature tight junction assembly.
• Facilitates tissue remodeling and wound healing by allowing transient barrier opening.
• Mediates microbial pathogenesis, as enteric bacteria and dietary components can modulate tight junction permeability.
• Contributes to cancer progression by promoting loss of cell-cell adhesion and increased invasiveness.
• Regulates paracellular transport of ions and solutes, impacting fluid balance and nutrient absorption.
• Involves crosstalk with polarity complexes and Rho GTPases, linking junction assembly to cell polarity [2,4,7,8].
• Provides targets for therapeutic intervention in inflammatory bowel disease and other barrier disorders.
• Serves as a model for studying dynamic regulation of cell-cell junctions in development and disease.
What Happens During negative regulation of bicellular tight junction assembly?
Initiation by External or Internal Cues
In simple terms: Something tells the cell to slow down or stop building tight junctions.
Negative regulation of tight junction assembly can be initiated by various cues, including microbial products, inflammatory cytokines, and changes in cell polarity. For instance, intestinal bacteria and dietary components can modulate tight junction permeability, often by activating signaling pathways that inhibit assembly. Additionally, dominant-negative E-cadherin expression can increase the extent of tight junction assembly, suggesting that cadherin-mediated adhesion normally restrains this process.
Involvement of Polarity Complexes
In simple terms: Proteins that control cell polarity can put the brakes on junction formation.
The Par-3/aPKC polarity complex directly interacts with tight junction components and can negatively regulate assembly. Par-3 controls tight junction assembly through the Rac exchange factor Tiam1, and modulation of this pathway can inhibit junction formation. The interdependence of Rho GTPases and apicobasal polarity further highlights how polarity cues can suppress tight junction assembly.
Regulation by Rho GTPases
In simple terms: Small molecular switches like Rac1 and RhoA can turn junction building on or off.
Rho GTPases, including Rac1 and RhoA, are key regulators of tight junction assembly. IQGAP1 controls tight junction formation through differential regulation of claudin recruitment, and its activity can be modulated to negatively regulate assembly. The balance between active and inactive GTPases determines whether junctions assemble or disassemble.
Modulation of Junctional Proteins
In simple terms: Changing the availability or function of junction proteins can stop assembly.
Exogenous expression of the amino-terminal half of ZO-3 perturbs junctional complex assembly, acting as a negative regulator. Similarly, claudin-10b and claudin-15 channel functions can be altered to affect junction integrity. These examples illustrate how interfering with junctional protein function can inhibit tight junction assembly.
Outcomes: Barrier Disruption and Permeability Changes
In simple terms: The result is a leakier barrier between cells.
The ultimate outcome of negative regulation of tight junction assembly is increased paracellular permeability and loss of barrier function. This can lead to pathological conditions such as inflammatory bowel disease and microbial invasion. In cancer, such disruption facilitates metastasis.
Key Genes Involved in GO:1903347 negative regulation of bicellular tight junction assembly
The following genes and proteins are key players in the negative regulation of bicellular tight junction assembly, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CDH1 | E-cadherin; dominant-negative expression increases tight junction assembly, indicating negative regulation | Studying cadherin crosstalk with tight junctions |
| PARD3 | Par-3; controls tight junction assembly via Rac exchange factor Tiam1 | Polarity complex regulation of junctions |
| TIAM1 | Rac exchange factor; mediates Par-3 effects on tight junction assembly | Rho GTPase signaling in junction regulation |
| IQGAP1 | Controls tight junction formation through differential claudin recruitment | Scaffold protein in junction assembly |
| CLDN10 | Claudin-10b; pore-lining residues affect channel function | Tight junction channel properties |
| CLDN15 | Claudin-15; pore-lining residues affect channel function | Tight junction channel properties |
| TJP3 | ZO-3; amino-terminal half perturbs junctional complex assembly | Dominant-negative studies of junction assembly |
| RHOA | Rho GTPase; regulates tight junction assembly and polarity | Cytoskeletal dynamics in junction regulation |
| RAC1 | Rho GTPase; involved in tight junction assembly and polarity | Signaling to junction assembly |
| PRKCI | aPKC; part of polarity complex interacting with tight junction components | Polarity complex regulation |
| CDH1 (context) | E-cadherin function inhibition increases tight junction assembly | Adhesion crosstalk |
| CLDN1 | Claudin family member; modulated by bacteria and diet | Barrier function studies |
| OCLN | Occludin; tight junction component affected by regulatory cues | Barrier permeability |
| TJP1 | ZO-1; scaffold protein in tight junctions | Junction assembly and regulation |
| TJP2 | ZO-2; scaffold protein in tight junctions | Junction assembly and regulation |
| ACTB | Actin; cytoskeletal component involved in junction dynamics | Cytoskeletal regulation |
| MYH9 | Myosin; contractility affects junction assembly | Cytoskeletal tension |
| CDC42 | Rho GTPase; regulates polarity and junction assembly | Polarity signaling |
How Is negative regulation of bicellular tight junction assembly Regulated?
The negative regulation of bicellular tight junction assembly is itself controlled by various signaling pathways. Rho GTPases, including Rac1, RhoA, and Cdc42, are central regulators that can either promote or inhibit assembly depending on context. Polarity complexes such as Par-3/aPKC interact with junctional proteins and can negatively regulate assembly through Tiam1-Rac signaling [4,8]. Additionally, microbial products and dietary components can modulate tight junction permeability by activating negative regulatory pathways. IQGAP1 acts as a scaffold that differentially regulates claudin recruitment, thereby influencing assembly. These regulatory layers ensure that tight junction assembly is finely tuned to physiological demands.
negative regulation of bicellular tight junction assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CDH1 | Cancer progression, metastasis | Knockout or dominant-negative overexpression in epithelial cell lines |
| PARD3 | Polarity disorders, cancer | Knockout and rescue with point mutants |
| TIAM1 | Cancer, barrier dysfunction | Knockout and overexpression studies |
| IQGAP1 | Cancer, barrier regulation | Knockout and tagged knock-in for localization |
| CLDN10 | Barrier disorders, channelopathies | Point mutations in pore-lining residues |
Inflammatory Bowel Disease and Barrier Dysfunction
Disruption of tight junction assembly is a hallmark of inflammatory bowel disease (IBD), where increased intestinal permeability leads to chronic inflammation. Negative regulation of tight junction assembly by pro-inflammatory cytokines and microbial factors contributes to barrier loss. Understanding these mechanisms may lead to therapies that restore barrier function.
Cancer Progression and Metastasis
Loss of tight junctions is associated with cancer progression, as it facilitates epithelial-mesenchymal transition and metastasis. Negative regulation of tight junction assembly can be hijacked by cancer cells to promote invasion. Targeting these pathways could inhibit metastatic spread.
Microbial Pathogenesis
Many enteric pathogens disrupt tight junctions to breach the epithelial barrier. They achieve this by activating host signaling pathways that negatively regulate tight junction assembly. Studying these interactions can inform strategies to prevent infection.
From negative regulation of bicellular tight junction assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate tight junction assembly? | CRISPR knockout in epithelial cells followed by barrier assays |
| What is the role of a specific phosphorylation site in protein Y? | Point mutation knock-in (e.g., phospho-dead or phospho-mimetic) |
| How does protein Z localization change during junction disassembly? | Tagged knock-in (e.g., GFP) and live-cell imaging |
| Can overexpression of gene W disrupt tight junctions? | Doxycycline-inducible overexpression in polarized cells |
| Which genes are essential for barrier maintenance? | Genome-wide CRISPR library screening with permeability readout |
| How do mutations in claudins affect channel function? | Point mutation knock-in in cell lines and electrophysiology |
How to Study the negative regulation of bicellular tight junction assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TEER | Transepithelial electrical resistance | Barrier integrity in epithelial monolayers |
| Paracellular flux | Permeability to tracers | Quantifying leakiness |
| Immunofluorescence | Localization of junction proteins | Visualizing assembly/disassembly |
| Co-immunoprecipitation | Protein-protein interactions | Identifying regulatory complexes |
| CRISPR knockout | Gene function loss | Testing causal roles |
| Point mutation knock-in | Effect of specific mutations | Dissecting phosphorylation sites |
| RNA-seq | Transcriptional changes | Global effects on junction genes |
| Proteomics | Protein abundance and modifications | Identifying signaling changes |
Barrier Function Assays
Transepithelial electrical resistance (TEER) and paracellular flux assays are standard methods to measure tight junction barrier function. These assays quantify the integrity of tight junctions and can detect changes due to negative regulation.
Imaging of Junction Assembly
Immunofluorescence and live-cell imaging of tight junction proteins (e.g., ZO-1, occludin, claudins) allow visualization of assembly and disassembly dynamics [2,6]. Tagged knock-in models enable real-time tracking.
Biochemical Analysis of Protein Interactions
Co-immunoprecipitation and pull-down assays can identify interactions between polarity complexes, GTPases, and junctional proteins [4,8]. These methods help elucidate molecular mechanisms of negative regulation.
Genome Editing and Functional Genomics
CRISPR-Cas9 knockout, point mutation, and knock-in models are powerful tools to dissect gene function in tight junction assembly [2,6,8]. Library screening can identify novel regulators.
How CRISPR Can Be Used to Study GO:1903347 negative regulation of bicellular tight junction assembly
Knockout
CRISPR knockout of candidate negative regulators (e.g., PARD3, TIAM1) can be used to test whether loss of function increases tight junction assembly. This approach provides causal evidence for gene involvement.
Point Mutation
Introducing point mutations in genes such as CLDN10 or CLDN15 can reveal the impact of specific residues on channel function and junction assembly. Phospho-dead or phospho-mimetic mutations in regulatory proteins can dissect signaling pathways.
Knock-in
Tagged knock-in of junctional proteins (e.g., GFP-ZO-1) allows real-time imaging of assembly dynamics in live cells. This helps visualize how negative regulators affect junction formation.
Overexpression
Overexpression of dominant-negative constructs (e.g., ZO-3 amino-terminal half) or wild-type proteins can perturb junction assembly and reveal negative regulatory mechanisms. Inducible systems allow temporal control.
How EDITGENE Supports negative regulation of bicellular tight junction assembly Research
Researchers studying negative regulation of bicellular tight junction assembly-related genes often need to determine whether a candidate gene is causally involved in junction disassembly or barrier modulation. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of bicellular tight junction assembly research.
Frequently Asked Questions About negative regulation of bicellular tight junction assembly
What is GO:1903347?
GO:1903347 is a Gene Ontology term for negative regulation of bicellular tight junction assembly, describing any process that stops, prevents, or reduces the frequency, rate, or extent of tight junction assembly.
What genes are involved in negative regulation of tight junction assembly?
Key genes include PARD3, TIAM1, IQGAP1, CDH1, CLDN10, CLDN15, TJP3, RHOA, RAC1, and PRKCI, among others [2,3,4,5,6,7,8].
How is tight junction assembly negatively regulated?
It is regulated by polarity complexes, Rho GTPases, and modulation of junctional protein function, often in response to microbial or inflammatory cues [1,2,4,7,8].
What diseases are associated with dysregulated tight junction assembly?
Diseases include inflammatory bowel disease, cancer progression, and microbial pathogenesis [1,5].
What methods are used to study negative regulation of tight junction assembly?
Common methods include TEER, paracellular flux, immunofluorescence, co-immunoprecipitation, and CRISPR-based gene editing [1,2,6].
How can CRISPR help study GO:1903347?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of gene function in tight junction assembly [2,6,8].
What is the role of Par-3 in tight junction assembly?
Par-3 controls tight junction assembly through the Rac exchange factor Tiam1, and its modulation can negatively regulate assembly.
How do Rho GTPases affect tight junction assembly?
Rho GTPases such as Rac1 and RhoA regulate tight junction assembly and apicobasal polarity, with their balance determining assembly outcomes.
Can bacteria negatively regulate tight junction assembly?
Yes, intestinal bacteria and dietary components can modulate tight junction permeability, often by activating negative regulatory pathways.
What cell models are suitable for studying negative regulation of tight junction assembly?
Epithelial cell lines (e.g., Caco-2, MDCK) with CRISPR modifications are widely used for barrier and imaging studies [1,2,6].
Conclusion
GO:1903347, negative regulation of bicellular tight junction assembly, is a critical biological process that controls epithelial barrier dynamics. Its dysregulation contributes to various diseases, making it an important area of research. By leveraging CRISPR-based models and advanced methodologies, researchers can uncover novel regulatory mechanisms and potential therapeutic targets. EDITGENE offers comprehensive services to support these endeavors.
References
- 1. Ulluwishewa D et al.. 2011. Regulation of tight junction permeability by intestinal bacteria and dietary components.. J Nutr 141(5):769-76 PMID: 21430248
- 2. Tanos BE et al.. 2015. IQGAP1 controls tight junction formation through differential regulation of claudin recruitment.. J Cell Sci 128(5):853-62 PMID: 25588839
- 3. Hempel C et al.. 2022. Tight junction channels claudin-10b and claudin-15: Functional mapping of pore-lining residues.. Ann N Y Acad Sci 1515(1):129-142 PMID: 35650657
- 4. Hurd TW et al.. 2003. Direct interaction of two polarity complexes implicated in epithelial tight junction assembly.. Nat Cell Biol 5(2):137-42 PMID: 12545177
- 5. Troxell ML et al.. 2000. Inhibiting cadherin function by dominant mutant E-cadherin expression increases the extent of tight junction assembly.. J Cell Sci 113 ( Pt 6):985-96 PMID: 10683147
- 6. Wittchen ES et al.. 2000. Exogenous expression of the amino-terminal half of the tight junction protein ZO-3 perturbs junctional complex assembly.. J Cell Biol 151(4):825-36 PMID: 11076967
- 7. Mack NA et al.. 2014. The interdependence of the Rho GTPases and apicobasal cell polarity.. Small GTPases 5(2):10 PMID: 25469537
- 8. Chen X et al.. 2005. Par-3 controls tight junction assembly through the Rac exchange factor Tiam1.. Nat Cell Biol 7(3):262-9 PMID: 15723052
